Navigation Links
Arena Pharmaceuticals Submits New Drug Application to FDA for Lorcaserin for Weight Management
Date:12/22/2009

or in the manner Arena expects or at all; Arena's ability to partner or commercialize lorcaserin or other of its compounds or programs; Arena's ability to obtain additional funds; Arena's ability to obtain and defend its patents; and the timing and receipt of payments and fees, if any, from Arena's collaborators. Additional factors that could cause actual results to differ materially from those stated or implied by Arena's forward-looking statements are disclosed in Arena's filings with the Securities and Exchange Commission. These forward-looking statements represent Arena's judgment as of the time of this release. Arena disclaims any intent or obligation to update these forward-looking statements, other than as may be required under applicable law.


    Contact: Arena Pharmaceuticals, Inc.     Media Contact: Russo Partners

    Jack Lief                                David Schull, President
    President and CEO                        david.schull@russopartnersllc.com
                                             212.845.4271

    Cindy McGee
    Manager, IR and Corporate Communications Anthony J. Russo, Ph.D., CEO
    cmcgee@arenapharm.com                    tony.russo@russopartne
'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Arena Pharmaceuticals to Present at Four Upcoming Investor Conferences
2. Arena Pharmaceuticals Announces Positive Phase 2 Clinical Trial Results of APD125 for the Treatment of Insomnia
3. Arena Pharmaceuticals Announces APD668 Initial Clinical Study Results Suggest Glucose-Dependent Insulinotropic Receptors May Improve Glucose Control in Patients With Type 2 Diabetes
4. Arena Pharmaceuticals Announces Positive Phase 1a Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis and Initiates Phase 1b Clinical Trial
5. Arena Pharmaceuticals Initiates Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia
6. Arena Pharmaceuticals, Inc. Announces Initiation of Phase 1 Clinical Trial of Drug Candidate Under Partnership with Taisho Pharmaceutical Co., Ltd.
7. Arena Pharmaceuticals Presented Positive Phase 2a Clinical Trial Results of APD125 for the Treatment of Insomnia at 22nd Annual Meeting of the Associated Professional Sleep Societies
8. Arena Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis
9. Critical Pharmaceuticals Enter Sustained Release hGH Arena
10. Arena Pharmaceuticals Announces Preliminary Results of Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia
11. Arena Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Type 2 Diabetes Drug Candidate in Partnership with Ortho-McNeil-Janssen Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... March 2, 2015   Polymedco is committed to supporting ... CRC Awareness Month, we are offering all existing customers ... , Posters – to be hung in patient ... Patient Brochures with Stand – to be placed in ... to be put on/in patient charts as a reminder ...
(Date:3/2/2015)... VANCOUVER, British Columbia and ... DelMar Pharmaceuticals, Inc. (OTCQX: ... on developing and commercializing proven cancer therapies in ... received a Notice of Allowance from the U.S. ... number 13/817,096 entitled, " Compositions and methods to ...
(Date:3/2/2015)... 2015  Sarnova, parent company of Tri-anim Health ... www.tri-anim.com website, continuing Tri-anim,s mission to ... respiratory, anesthesia and other critical care supplies and ... site has many new features and enhanced functionality ... and ordering easier and more efficient for the ...
Breaking Medicine Technology:Polymedco CDP, LLC. Promotes March as Colorectal Cancer Awareness Month 2DelMar Pharmaceuticals Receives Notice of Allowance of Fourth U.S. Patent Covering Methods of Use and Compositions for VAL-083 2DelMar Pharmaceuticals Receives Notice of Allowance of Fourth U.S. Patent Covering Methods of Use and Compositions for VAL-083 3DelMar Pharmaceuticals Receives Notice of Allowance of Fourth U.S. Patent Covering Methods of Use and Compositions for VAL-083 4Tri-anim Health Services Launches New Website Featuring Improved Product Selection and Ease of Ordering 2Tri-anim Health Services Launches New Website Featuring Improved Product Selection and Ease of Ordering 3
... TARRYTOWN, N.Y., Nov. 2, 2011 Siemens Healthcare Diagnostics ... a partnership aimed at setting new standards in ... of patients, infectious disease states and potential treatment paths. ... make existing Siemens molecular HIV tests compatible with the recently ...
... world leader in diabetes care, announced today that it has ... (DHF), a non-profit organization that raises diabetes awareness and connects ... of the Drive the Switch program, which has motivated more ... and their doctor about options for insulin delivery, like the ...
Cached Medicine Technology:New Siemens - Illumina Partnership Targets Clinical Infectious Disease Testing Using Next-Generation Sequencing 2New Siemens - Illumina Partnership Targets Clinical Infectious Disease Testing Using Next-Generation Sequencing 3Novo Nordisk Donates $50,000 to Diabetes Hands Foundation in Recognition of the Drive the Switch Program's Inaugural Year 2Novo Nordisk Donates $50,000 to Diabetes Hands Foundation in Recognition of the Drive the Switch Program's Inaugural Year 3Novo Nordisk Donates $50,000 to Diabetes Hands Foundation in Recognition of the Drive the Switch Program's Inaugural Year 4Novo Nordisk Donates $50,000 to Diabetes Hands Foundation in Recognition of the Drive the Switch Program's Inaugural Year 5Novo Nordisk Donates $50,000 to Diabetes Hands Foundation in Recognition of the Drive the Switch Program's Inaugural Year 6Novo Nordisk Donates $50,000 to Diabetes Hands Foundation in Recognition of the Drive the Switch Program's Inaugural Year 7
(Date:3/2/2015)... 02, 2015 LegitScript, LLC, ... certification programs, including those for Internet pharmacy ... safety and classification, has launched a certification ... The new program, called iCareRx , ... regarding the identity of the owner/operator of ...
(Date:3/2/2015)... 2015 Atlantic Information Services, Inc. (AIS) ... Directory of Health Plans: 2015 , the all-new 12th ... U.S. health plan market, with enrollment data and contact ... , Available as a printed book containing the ... in quick-view tables and charts, as well as an ...
(Date:3/2/2015)... Regulatory Compliance Associates® Inc. (RCA), ... and technical consulting, announces Mr. Seyed Khorashahi has ... , Before joining RCA, Mr. Khorashahi had over ... all aspects of developing safety-critical medical devices. ... Regulatory Compliance Associates Inc., Baxter Healthcare, and Beckman ...
(Date:3/2/2015)... In light of the FDA's approved ... (rivaroxaban) tablets, Ford & Associates Nationwide Legal Services ... future users, but may come too late for individuals ... drug. The FDA has now included the term “thrombocytopenia,” ... Xarelto's label. The term “cytolytic hepatitis” has also been ...
(Date:3/2/2015)... Dhaka, Bangladesh (PRWEB) March 02, 2015 ... appointment of fire safety expert Mark Chubb to serve ... oversee fire safety operations and training in Bangladesh and ... Members source. , “Mark will ensure that the ... and fire safety programs for Bangladesh garment workers,” said ...
Breaking Medicine News(10 mins):Health News:LegitScript Launches Certification Program for Internet Eyeglass Sellers 2Health News:Now Available from AIS: 12th Edition of Annual Book Containing Health Plan Enrollment Data, Contact Information 2Health News:Regulatory Compliance Associates® Inc. Welcomes Seyed Khorashahi as Chief Operating Officer 2Health News:Ford & Associates Nationwide Legal Services, A.P.C., Comments on Xarelto Lawsuits Upon FDA Revisions 2Health News:Ford & Associates Nationwide Legal Services, A.P.C., Comments on Xarelto Lawsuits Upon FDA Revisions 3Health News:Ford & Associates Nationwide Legal Services, A.P.C., Comments on Xarelto Lawsuits Upon FDA Revisions 4Health News:Alliance for Bangladesh Worker Safety Names New Chief Safety Officer 2
... June 13 Digirad Corporation,(Nasdaq: DRAD ), ... services to physicians, offices, hospitals and imaging centers, ... presenting at CapStone,Investments, Second Annual Small-Cap Investor Conference ... Center in Milwaukee., Casner,s 30-minute presentation, including ...
... of $15 Million for recent disasters, WASHINGTON, June ... it moves forward with relief efforts for,the victims of ... From Kansas to West Virginia, the Red Cross is ... shelters and tens of,thousands of meals., Already, more ...
... disease sooner, when it,s more treatable , , FRIDAY, June 13 ... pancreatic cancer have been identified by U.S. researchers, who said ... a blood test to detect this type of cancer in ... "Our team identified, for the first time, protein changes associated ...
... Paris, France, Friday 13 June 2008: The TRAF1/C5 locus ... role in multiple autoimmune diseases including type 1 diabetes ... presented today at EULAR 2008, the Annual Congress of ... , TRAF1 (Tumour Necrosis Factor-receptor associated factor 1) and ...
... June 2008: Tocilizumab plus methotrexate showed significant clinical ... moderate to severe rheumatoid arthritis (RA), who had ... therapy, according to a new study presented today ... European League Against Rheumatism in Paris, France. Tocilizumab, ...
... to be Smoke-Free in 90 Days, HARRISBURG, Pa., ... law the Clean Indoor Air Act, which will protect,Pennsylvanians ... smoking in most public places, including restaurants,workplaces and a ... from the persistence of advocates and,legislators who refused to ...
Cached Medicine News:Health News:Digirad Corporation to Present at CapStone Small-Cap Investor Conference 2Health News:American Red Cross Issues Appeal for Disaster Relief Fund 2Health News:Pancreatic Cancer Biomarkers Found 2Health News:Specific location of the TRAF1/C5 gene associated with multiple autoimmune diseases 2Health News:30 percent RA patients refractory to anti-TNFs achieve disease remission with tocilizumab plus metho 2Health News:Governor Rendell Signs Bill Restricting Smoking in Most Public Places in Pennsylvania 2Health News:Governor Rendell Signs Bill Restricting Smoking in Most Public Places in Pennsylvania 3
... Chart Manager information can be input ... are not limited to drop-down lists ... each person to document individually. Patient ... valuable data and communication. All this ...
AllMeds was the first specialty-specific Electronic Medical Record for Orthopaedics. Instead of trying to force a general-purpose EMR into your practice, AllMeds starts with clinical content from Ort...
... software It runs over hospital ... PAS systems and some items ... collects data at initial consultation, ... checks, operation, post-op checks, telephone ...
... such as prescription writing, referral letters, chart ... will be ,able to add more appointments ... staff., Based on the exam documentation created ... recommend the appropriate E&M ,code for the ...
Medicine Products: